APOA1 and coronary artery disorder: The levels of IgG for anti-ApoA-I251–262, anti-ApoA-I251–262 HNE, anti-ApoA-I70–83, and anti-ApoA-I70–83 HNE did not significantly differ among CAD patients with various levels of stenosis (<30%, 30%~70%, and >70%) versus HCs (Figure 3A,B).